NATCOPHARM

HealthcareDrug Manufacturers - Specialty & GenericMid Cap
NATCO Pharma Limited

NATCO Pharma Limited (NATCOPHARM) is a Hyderabad, India-headquartered pharmaceutical company, incorporated in 1981, operating in the Healthcare sector as a Specialty & Generic Drug...

हिन्दी में

NATCO Pharma Limited (NATCOPHARM) हैदराबाद, भारत में मुख्यालय वाली एक फार्मास्युटिकल कंपनी है, जिसे 1981 में निगमित किया गया था, जो हेल्थकेयर क्षेत्र में एक स्पेशलिटी और जेनेरिक ड्...

₹789.4-0.75%1D
Previous trading day close · Data updates after market close
1W: -3.9%
1M: -4.5%
6M: -26.7%
1Y: -2.7%
79/100
GoodResearch Score
Market Cap
₹16.2K Cr
Mid Cap
P/E Ratio
11.76
Below avg
P/B Ratio
2.19
Reasonable
ROE
28.0%
Strong
ROCE
19.9%
Excellent
Debt / Equity
0.04
Low debt
Div. Yield
0.5%
Low yield
EV/EBITDA
8.34
Attractive
52W Low: ₹787.45Current: ₹789.452W High: ₹1,226.8
At 0% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
85/100
Growth
Revenue, EPS, profit growth
78/100
Valuation
PE, PB, EV/EBITDA vs sector
86/100
Risk
Debt levels, volatility, coverage
80/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
11.76(Below avg)
Forward P/E
22.83(Premium)
P/B Ratio
2.19(Reasonable)
P/S Ratio
3.81(Good)
EV/EBITDA
8.34(Attractive)
Dividend Yield
0.5%
5Y CAGR
-4.1%(Moderate)
Revenue Growth
-8.5%(Moderate)
Profitability
ROE
28.0%(Excellent)
ROCE
19.9%(Excellent)
ROA
24.3%(Efficient)
Net Margin
32.4%(High)
EBITDA Margin
39.6%
Financial Health
Debt to Equity
0.04(Low debt)
Current Ratio
5.59(Healthy)
Quick Ratio
4.77(Good)
Interest Coverage
41.62x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
40(Neutral)
RSI Exp (14)
20(Oversold)
MACD
-13.762(Bearish)
MACD Signal
-12.636
BB Position
-6%(Lower band)
BB Width
6.74%(Normal)
ADX (14)
16.3(Sideways)
Williams %R
-97.2(Oversold)
MFI (14)
30(Neutral)
CCI (20)
-184(Oversold)
Stoch %K
3(Oversold)
ATR (14)
21.49(Avg True Range)
OBV (M)
104.9(Positive)
1W OBV Chg
-0.2%(Decreasing)
Rel Volume
0.54x(Normal)
Volatility
38.3%(Moderate)
Max DD 1Y
-50.0%(High loss)
EMA 200
921.5
EMA 50
854.9
SMA 200
940.4
vs SMA 50
-8.0%(Below SMA50)
vs SMA 200
-16.1%(Below SMA200)
Volume
2.33L
Avg Vol 3M
4.3L
Shareholding Pattern
Promoter
49.4%
Moderate
FII
17.4%
DII / MF
5.5%
Share NATCOPHARM
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.